METTL3 was found to inhibit the expression of zinc finger protein 750 (ZNF750) and downregulate the expression of fibroblast growth factor 14 (FGF14) in NPC, which promoted NPC development and progression [94]. The gene discussed is METTL3; the disease is nasopharyngeal carcinoma.